# Protara Therapeutics, Inc.: Form 8-K, filed Dec 11, 2024

- Company: [Protara Therapeutics, Inc.](/companies/tara.md) (CIK 1359931)
- Form: 8-K
- Filed: 2024-12-11
- Accepted by EDGAR: Dec 11, 2024, 16:19 ET
- Period: 2024-12-09
- Accession: 0001213900-24-107906
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1359931/000121390024107906/ea0224389-8k_protara.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1359931/000121390024107906/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1359931/000121390024107906/ea0224389-8k_protara.htm

Filed Dec 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-107906. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.